BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+17.56%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$6.54B
AUM Growth
+$331M
(+5.3%)
Cap. Flow
-$370M
Cap. Flow
% of AUM
-5.66%
Top 10 Holdings %
Top 10 Hldgs %
39.82%
Holding
179
New
25
Increased
33
Reduced
89
Closed
18
Top Buys
| 1 |
Immunocore
IMCR
|
$65.3M |
| 2 |
Biohaven
BHVN
|
$46M |
| 3 |
Moderna
MRNA
|
$41.1M |
| 4 |
GE HealthCare
GEHC
|
$40.4M |
| 5 |
Boston Scientific
BSX
|
$30.3M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
$108M |
| 2 |
UnitedHealth
UNH
|
$63.2M |
| 3 |
Evolent Health
EVH
|
$42.9M |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
$34.5M |
| 5 |
IQVIA
IQV
|
$34M |
Sector Composition
| 1 | Healthcare | 99.06% |
| 2 | Industrials | 0.83% |
| 3 | Energy | 0.03% |
| 4 | Consumer Discretionary | 0.02% |
| 5 | Communication Services | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Beam Therapeutics
BEAM
$1.9B
| $18.9M | 0.29% |
694,821
| – | – |
|
77
Thermo Fisher Scientific
TMO
$183B
| $18.8M | 0.29% |
35,342
-31,126
| -47% | -$16.5M |
|
78
Fate Therapeutics
FATE
$115M
| $18.1M | 0.28% |
4,851,579
| – | – |
|
|
SILK
79
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $17.6M | 0.27% |
1,435,682
+5,120
| +0.4% | +$62.8K |
|
|
VRNA
80
Verona Pharma
VRNA
$9.18B
| $16.7M | 0.26% |
839,996
-16,362
| -2% | -$325K |
|
81
10x Genomics
TXG
$1.66B
| $16.4M | 0.25% |
293,173
-1,259
| -0.4% | -$70.5K |
|
82
Natera
NTRA
$23B
| $16.1M | 0.25% |
256,584
-1,102
| -0.4% | -$69K |
|
83
Esperion Therapeutics
ESPR
$490M
| $12.6M | 0.19% |
4,204,264
| – | – |
|
84
Legend Biotech
LEGN
$6.64B
| $12.1M | 0.19% |
201,754
-76,400
| -27% | -$4.6M |
|
85
Amgen
AMGN
$153B
| $9.85M | 0.15% |
34,205
-14,268
| -29% | -$4.11M |
|
86
Phreesia
PHR
$1.81B
| $9.76M | 0.15% |
421,573
-157,466
| -27% | -$3.65M |
|
87
Outset Medical
OM
$245M
| $9.52M | 0.15% |
117,342
-43,220
| -27% | -$3.51M |
|
88
Regeneron Pharmaceuticals
REGN
$59.8B
| $9.41M | 0.14% |
10,709
-4,230
| -28% | -$3.72M |
|
89
Omnicell
OMCL
$1.51B
| $8.42M | 0.13% |
223,816
-15,463
| -6% | -$582K |
|
90
Doximity
DOCS
$12.6B
| $7.4M | 0.11% |
264,035
-135,422
| -34% | -$3.8M |
|
91
Illumina
ILMN
$15.2B
| $6.26M | 0.1% |
46,253
-27,794
| -38% | -$3.76M |
|
92
Generation Bio
GBIO
$40.3M
| $5.97M | 0.09% |
361,708
| – | – |
|
93
Teladoc Health
TDOC
$1.37B
| $5.59M | 0.09% |
259,404
-96,245
| -27% | -$2.07M |
|
94
ResMed
RMD
$39.4B
| $5.22M | 0.08% |
30,320
-46,376
| -60% | -$7.98M |
|
|
ONC
95
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.5B
| $5.21M | 0.08% |
28,600
-24,600
| -46% | -$4.48M |
|
96
Johnson & Johnson
JNJ
$429B
| $4.43M | 0.07% |
28,280
+5,457
| +24% | +$855K |
|
|
NVRO
97
DELISTED
NEVRO CORP.
NVRO
| $4.25M | 0.07% |
197,324
-847
| -0.4% | -$18.2K |
|
98
Dr. Reddy's Laboratories
RDY
$11.8B
| $4.24M | 0.06% |
304,500
-96,500
| -24% | -$1.34M |
|
99
Gilead Sciences
GILD
$140B
| $4.16M | 0.06% |
51,305
-56,045
| -52% | -$4.54M |
|
|
MTEM
100
DELISTED
Molecular Templates, Inc.
MTEM
| $3.84M | 0.06% |
1,029,820
-1,793
| -0.2% | -$6.69K |
|